Talis Biomedical (TLIS) - 2023 Q2 - Earnings Call Transcript

Mark Massaro - BTIG Except required by law, Talis Bio disclaims any intention or obligation to update or revise any financial projection or forward-looking statement whether because of new information, future events, or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast on August 10th, 2023. Our initial planned test menu consists of a Respiratory Panel for Influenza A, Influenza B in COVID-19 or Fluid, Chlamydia, gonorrhoeae, and Trichomonas vag ...